Table: Aska Pharmaceutical -Q1 group results

ASKA Pharmaceutical Holdings

06/08/2018 07:00

Aug 6 (Reuters)- 
             Aska Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.76               12.81            49.00    
                 (-0.4 pct)          (+6.9 pct)       (+0.1 pct)  
  Operating          1.22                1.08             1.00    
                 (+13.1 pct)        (+132.8 pct)      (-64.6 pct) 
  Recurring          1.36                1.17             1.20    
                 (+15.5 pct)         (+97.1 pct)      (-61.0 pct) 
  Net                1.06                1.04             1.00    
                 (+1.8 pct)          (+98.3 pct)      (-58.1 pct) 
  EPS             37.67 yen           37.10 yen        35.47 yen  
  Ann Div                             14.00 yen        14.00 yen  
  -Q2 div                             7.00 yen         7.00 yen   
  -Q4 div                             7.00 yen         7.00 yen   
  
  NOTE - Aska Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T